I G MicroMed Environmental Inc

The Friedman Lab is a translational research group within the University of British Columbia's Department of Medical Genetics, located at the Children's and Women's Health Centre in Vancouver, Canada. Led by Professor Jan M. Friedman, the lab comprises a multidisciplinary team of experts in clinical genetics, clinical genomics, clinical teratology, genetic counselling, and health services research. The group's primary objective is to enhance the care of families affected by genetic disorders, focusing on three key areas: the genetic causes of intellectual disability, neurofibromatosis, and birth defect epidemiology. All research conducted at the Friedman Lab is collaborative, aiming to advance understanding and treatment in these critical fields. Generated from the website

The Investigational Drug Program (IDP) at the BC Cancer Agency offers fee-for-service preclinical research and contract manufacturing services to both academic and private sector researchers. With a focus on cancer therapeutics, IDP collaborates closely with its partners to advance promising therapeutic compounds to the stage of early-phase human clinical trials. Equipped with fully compliant GLP and GMP facilities, IDP has successfully produced over 130 distinct batches of injectable experimental drug formulations. The program's highly skilled team provides comprehensive management of in vitro and in vivo research services, ensuring timely and cost-effective guidance for product development through established relationships with oncology specialists. Generated from the website

The Silencer, based in Vancouver, BC, has been a trusted solution for dentists and their patients since the early 1990s, providing an innovative oral appliance designed to alleviate snoring and sleep apnea. Invented by Dr. Wayne Halstrom, the device features a unique titanium component known as the Halstrom Hinge, which enhances its effectiveness and comfort. Recognized for its contributions to sleep health, The Silencer has garnered attention for its role in promoting awareness of sleep apnea and its associated risks. The company is committed to advancing treatment options and improving the quality of life for individuals affected by sleep disorders. Generated from the website